Navigation Links
New paper calls for strong steps to tackle antibiotic resistance
Date:12/8/2011

Shahriar Mobashery, a University of Notre Dame researcher, is one of the coauthors of a new paper by a group of the world's leading scientists in academia and industry that calls for strong steps to be taken to control the global crisis of antibiotic resistance in bacteria. The group issued a priority list of steps that need to be taken on a global scale to resolve the crisis.

The paper is an outgrowth of a meeting the group held at the Banbury Conference Centre in Cold Spring Harbor, N.Y., to discuss the crisis and it appears in the journal Nature Reviews Microbiology.

The group notes that in Europe in 2007, the number of infections by multidrug-resistant bacteria was 400,000 and there were 25,000 attributable deaths.

In the United States alone, antibiotic-resistant infections are responsible for $20 billion per year in excess health care costs, $35 billion per year in societal costs and 8 million additional hospital stays per year.

The problem of resistance is compounded by the fact that we live in a global economy, resulting in a worldwide spread of antibiotic-resistant genes.

The Banbury group recommends that research priorities be established to control resistance.

They point out that additional basic information about resistance is required to address the crisis.

"Increasing lines of evidence identify the principal reservoirs of resistance genes to be bacteria that live in and on humans and animals, as well as those found in the environment (in soil, water and so on)," the paper notes. "However, there is insufficient information about the conditions and factors that lead to the mobilization, selection and movement of these bacteria into and between animal and human populations."

The report also calls for increased international funding to enable scientists to track new antibiotic-resistance threats worldwide, in a manner similar to how the World Health Organization and other agencies track influenza out breaks.

The paper points out that antibiotic resistance is life-threatening in the same sense as cancer, both in the number of cases and the likely outcome. It therefore calls for a public education campaign about bacteria and antibiotic resistance similar to those that have been mounted for cancer awareness.

The study also notes that in some parts of the world, population density, the uncontrolled use of antibiotics, a lack of both a clean water supply and proper treatment for sewage and industrial effluent create the conditions that disseminate and select resistant bacteria.

"Local governments must be encouraged and supported to invest in better sanitation infrastructure and tighter prescription regulations to control the rapid evolution of resistance," the scientists said. "This is a worldwide, multinational problem and must be treated as such."

The group also notes that it is essential to develop a continuous supply of new antibiotics that are not affected by known or existing mechanisms of resistance. The economics of pharmaceutical drug development offer little incentive for companies to develop new antibiotics, since the drugs are used on an episodic, rather than continual, basis. New public-private partnerships must develop to overcome the economics barriers facing the development o new antibiotics.

The Banbury participants also call for better control of antibiotic use, repurposing of old antibiotics to battle resistance and new alternatives to antibiotics.

The group's paper concludes, "The cost of the undertaking that we propose will be infinitesimally small in comparison to the economic and human cost of doing nothing."


'/>"/>

Contact: Shahriar Mobashery
mobashery@nd.edu
574-631-2933
University of Notre Dame
Source:Eurekalert

Related medicine news :

1. Cloud Computing Platforms Address Unique M2M Application Needs, According To New SensorLogic White Paper
2. Paper Kills 2.0 Book by Center for Health Transformation Features Chapter by StatCom
3. buySAFE, Inc. Releases a Breakthrough White Paper that is a Must Read for Every Internet Retailer Interested in Increasing Website Conversion
4. SEBM Best Paper Awards for articles published in 2009
5. Stonebranch Publishes Healthcare IT White Paper
6. PCI Compliance and Data Security Requires Private Key Management – New Industry White Paper Explains
7. Centice Corporation Releases a Two Part Whitepaper on its PASS Rx Pharmacy Quality Solution
8. PaperFree Florida to help move physicians towards electronic health records
9. Go Green With Your Curriculum by Choosing A Paperless Option
10. FileHold Document Management Software Helps National Tax Consulting Firm Reduce Paper and Streamline Tax Preparation for Their Clients
11. Wyatt Matas & Associates Releases White Paper on Future Home Healthcare Business Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Mt. Angel Vitamins, ... a months-long rebranding effort. This includes the introduction of new packaging and messaging, ... market research, we learned that a simple, proactive approach to wellness is important ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 ... alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To ... 1512, which proposes a tax on prescription opioids to fund drug rehabilitation and ...
(Date:3/26/2017)... , ... March 26, 2017 , ... ... to receive the RealSelf 100 Award, a prestigious award honoring the top influencers ... and to find and connect with doctors and clinics. , In 2016, more ...
(Date:3/24/2017)... ... 2017 , ... Clean Earth, Inc., a leader in providing ... materials announced today the acquisition of privately owned AERC Recycling Solutions ... facilities and a vast array of additional technologies, services, and new markets to ...
(Date:3/24/2017)... NY (PRWEB) , ... March 24, 2017 , ... ... scale; from third world countries to hospitals in the United States, it’s a ... conversation on the current obstacles facing infection prevention and offers strategies for the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017  Sanderling Ventures, portfolio company, Torax ... division of Johnson & Johnson. Torax manufactures and markets ... of gastro-esophageal reflux disease (GERD). The LINK device ... and the procedure is currently available in the ... Medical was founded by Sanderling Ventures, Mayo Medical ...
(Date:3/27/2017)... 27, 2017 BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today that AGI-134, an immunotherapy for the treatment of multiple ... will be featured at the upcoming American Association for ... DC to be held on April 1-5, 2017. ... An ...
(Date:3/27/2017)... 2017 The global clinical ... billion by 2025, according to a new study by ... diseases is anticipated to be responsible for the high ... the scope for growth during the forecast period. In ... is highly susceptible to chronic diseases, is presumed to ...
Breaking Medicine Technology: